Friday, July 30, 2010

CBSA Video Recap Now Posted: 7/28 CEO BioBreakfast With Drs Larry Gold and Bill Freytag, plus Mr. Patrick Mahaffy

Drs. Bill Freytag and Larry Gold, plus Mr. Patrick Mahaffy (L-R) explained what propelled them to grow successful bioscience companies and become leaders of the industry at the CBSA's July BioBreakfast event. Starting any business requires determination, self-discipline, persistence, a high tolerance for risk and a willingness to work very long hours. Starting a bioscience company with the goal of gaining FDA approval for a new drug or medical device requires incredible perseverance and an awful lot of money.

Thank you to the Colorado Science + Technology Park at Fitzsimons, Pfizer, Johnson and Johnson and OSI Pharmaceuticals for sponsoring! Video recaps are now available at the CBSA YouTube page:

Dr. Bill Freytag serves as a member of the board of directors for four health care companies: ARCA biopharma, Inc.; GlobeImmune, Inc.; ProFoldRx, Inc., and BiOptix Inc. Dr. Freytag was Chairman and Chief Executive Officer of Aspreva Pharmaceuticals until its merger with Galenica AG. Prior to Aspreva, Dr. Freytag was President, Chief Executive Officer and Chairman of the Board of Directors of Myogen, Inc. until it was acquired by Gilead.

"It's All About Good Science"

"Triaging A New Idea"

"On Mistakes"

"On Regrets"

"Best Piece Of Advice"

Dr. Larry Gold is the founder, Chairman of the Board and Chief Executive Officer of SomaLogic. Prior to SomaLogic, he founded NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc.

"Focusing On Early Detection"

"On Genomics"

"Don't Fall In Love With Your Idea"

"On Best Advice From A Venture Capitalist"

"On Teamwork"

Mr. Patrick Mahaffy co-founded Clovis Oncology and is its President and Chief Executive Officer. Previously, he served in the same role at Pharmion Corporation, which he founded in 2000. Prior to that, Mr. Mahaffy wasPresident and Chief Executive Officer of NeXagen, Inc. and its successor, NeXstar Pharmaceuticals, Inc. Today he is also a member of the boards of directors of Orexigen Therapeutics, Inc. and Flexion Therapeutics, Inc.

"This Is Not An Industry For Shortcuts"

"Shortcut Horror Story"

"It's A Game of Incremental Steps"

"More On Idea Triage"

"My Biggest Struggle"

"What Keeps Me Motivated"

"I Don't Live In A Regret World"

"On Current Funding Situation"

No comments:

Post a Comment